Display options
Share it on

Nephron Extra. 2011 Jan;1(1):9-23. doi: 10.1159/000330428. Epub 2011 Aug 04.

Urinary Neutrophil Gelatinase-Associated Lipocalin Measured on Admission to the Intensive Care Unit Accurately Discriminates between Sustained and Transient Acute Kidney Injury in Adult Critically Ill Patients.

Nephron extra

Hilde R H de Geus, Jessica G Woo, Yu Wang, Prasad Devarajan, Michiel G Betjes, Jos L M L le Noble, Jan Bakker

Affiliations

  1. Departments of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.

PMID: 22470375 PMCID: PMC3290847 DOI: 10.1159/000330428

Abstract

BACKGROUND: First we aimed to evaluate the ability of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin-C (CyC) in plasma and urine to discriminate between sustained, transient and absent acute kidney injury (AKI), and second to evaluate their predictive performance for sustained AKI in adult intensive care unit (ICU) patients.

METHODS: A prospective cohort study of 700 patients was studied. Sample collection was performed over 8 time points starting on admission.

RESULTS: After exclusion 510 patients remained for the analysis. All biomarkers showed significant differentiation between sustained and no AKI at all time points (p ≤ 0.0002) except for urine CyC (uCyC) on admission (p = 0.06). Urine NGAL (uNGAL) was the only biomarker significantly differentiating sustained from transient AKI on ICU admission (p = 0.02). Individually, uNGAL performed better than the other biomarkers (area under the curves, AUC = 0.80, 95% confidence interval, CI = 0.72-0.88) for the prediction of sustained AKI. The combination with plasma NGAL (pNGAL) showed a nonsignificant improvement (AUC = 0.83, 95% CI = 0.75-0.91). The combination of individual markers with a model of clinical characteristics (MDRD eGFR, HCO(3) (-) and sepsis) did not improve its performance significantly. However, the integrated discrimination improvement showed significant improvement when uNGAL was added (p = 0.04).

CONCLUSIONS: uNGAL measured on ICU admission differentiates patients with sustained AKI from transient or no-AKI patients. Combining biomarkers such as pNGAL, uNGAL and plasma CyC with clinical characteristics adds some value to the predictive model.

Keywords: Acute kidney injury; Cystatin C; Intensive care unit; Neutrophil gelatinase-associated lipocalin; Renal replacement therapy; Sustained acute kidney injury

References

  1. Ann Intern Med. 1999 Mar 16;130(6):461-70 - PubMed
  2. Kidney Int. 2007 Feb;71(3):239-44 - PubMed
  3. Kidney Int. 2008 Oct;74(8):1059-69 - PubMed
  4. Clin J Am Soc Nephrol. 2010 Mar;5(3):395-401 - PubMed
  5. Crit Care. 2010;14(3):R85 - PubMed
  6. Crit Care. 2008;12(3):R74 - PubMed
  7. J Am Soc Nephrol. 2004 Dec;15(12):3073-82 - PubMed
  8. Kidney Int. 2004 Sep;66(3):1115-22 - PubMed
  9. Nature. 2004 Dec 16;432(7019):917-21 - PubMed
  10. J Am Soc Nephrol. 2007 Feb;18(2):407-13 - PubMed
  11. Kidney Int. 2008 Feb;73(4):465-72 - PubMed
  12. Nephrol Dial Transplant. 2010 Jun;25(6):1833-9 - PubMed
  13. Crit Care Med. 2002 Sep;30(9):2051-8 - PubMed
  14. JAMA. 2005 Aug 17;294(7):813-8 - PubMed
  15. Intensive Care Med. 2010 Mar;36(3):444-51 - PubMed
  16. N Engl J Med. 2001 Nov 8;345(19):1368-77 - PubMed
  17. J Card Surg. 2004 Jan-Feb;19(1):17-20 - PubMed
  18. J Am Soc Nephrol. 2007 Mar;18(3):904-12 - PubMed
  19. Clin J Am Soc Nephrol. 2006 Jan;1(1):43-51 - PubMed
  20. N Engl J Med. 2006 Jun 15;354(24):2564-75 - PubMed
  21. Nephrol Dial Transplant. 2010 Oct;25(10):3283-9 - PubMed
  22. Nephrol Dial Transplant. 2009 Nov;24(11):3263-5 - PubMed
  23. Clin J Am Soc Nephrol. 2006 Sep;1(5):915-9 - PubMed
  24. Crit Care. 2007;11(6):R127 - PubMed
  25. Kidney Int. 2006 Jul;70(1):199-203 - PubMed
  26. Crit Care. 2005 Apr;9(2):R139-43 - PubMed
  27. Am J Physiol Renal Physiol. 2008 Apr;294(4):F731-8 - PubMed
  28. Clin Chem. 2002 May;48(5):699-707 - PubMed
  29. Kidney Int. 2004 Aug;66(2):496-9 - PubMed
  30. Crit Care Med. 2009 Jan;37(1 Suppl):S65-8 - PubMed
  31. Crit Care Med. 2009 Feb;37(2):553-60 - PubMed
  32. Clin Chem. 2004 Mar;50(3):552-8 - PubMed
  33. Gynecol Oncol. 2010 Jun;117(3):440-5 - PubMed
  34. Curr Opin Nephrol Hypertens. 2006 Jul;15(4):442-9 - PubMed
  35. Eur J Cardiothorac Surg. 2004 Nov;26(5):1027-31 - PubMed
  36. Biomarkers. 2009 Sep;14(6):423-31 - PubMed
  37. Ann Intern Med. 2008 Jun 3;148(11):810-9 - PubMed
  38. Crit Care Med. 2009 Jan;37(1):96-104 - PubMed
  39. Am J Kidney Dis. 2002 Aug;40(2):221-6 - PubMed
  40. Lancet. 2005 Apr 2-8;365(9466):1231-8 - PubMed
  41. Clin Nephrol. 2004 Nov;62(5):344-50 - PubMed
  42. Kidney Int. 2008 May;73(9):1008-16 - PubMed
  43. J Am Soc Nephrol. 2009 Aug;20(8):1823-32 - PubMed
  44. J Am Soc Nephrol. 2003 Jan;14(1):265-7 - PubMed
  45. Crit Care. 2004 Aug;8(4):R204-12 - PubMed
  46. J Crit Care. 2010 Mar;25(1):176.e1-6 - PubMed
  47. Am J Respir Crit Care Med. 2011 Apr 1;183(7):907-14 - PubMed

Publication Types